Literature DB >> 32858130

Preparation and characterization of a synthetic curcumin analog inclusion complex and preliminary evaluation of in vitro antileishmanial activity.

Luciana Matos Alves Pinto1, Oluwatomide Adeoye2, Sérgio Scherrer Thomasi3, Ana Paula Francisco2, Manuela Colla Carvalheiro2, Helena Cabral-Marques4.   

Abstract

The aim of this work was to prepare and characterize inclusion complexes between a synthetic curcumin analog (dibenzalacetone, DBA) and beta-cyclodextrin (β-CD); and to evaluate their in vitro antileishmanial activity. DBA was synthetized and characterized by spectroscopic methods and the inclusion complexes were obtained by kneading and lyophilization (LIO) in 1:1 and 1:2 stoichiometries. Phase solubility and dissolution assays showed a 40-fold increase in the aqueous solubility of DBA and its complete dissolution from LIO 1:1 formulation after 120 min respectively. Solid-state characterization by differential scanning calorimetry and near infrared spectroscopy demonstrated the inclusion of DBA in the β-CD cavity at the molar ratios tested, with LIO 1:1 formulation being the most stable. Using nuclear magnetic resonance experiments, the protons inside the cavity of β-CD were the most affected after the inclusion of DBA molecule. The cellular viability of THP-1 macrophage cells treated with plain DBA, β-CD and DBA/CD inclusion complexes showed that the plain DBA and DBA/CD at 1:2 stoichiometry presented toxicity, while β-CD alone and DBA/CD at 1:1 stoichiometry showed no toxicity up to 640 μg mL-1. The in vitro assay with free-living promastigotes demonstrated that plain DBA and β-CD had IC50 of < 10 and > 320 μg mL-1 respectively, while only inclusion complexes with 1:1 stoichiometry showed antiproliferative activity with IC50 = 51.3 μg mL-1. Using the amastigote intracellular forms, there was also a difference between the plain and β-CD complexed DBA with complexes of 1:1 and 1:2 stoichiometry presenting EC50 = 66.3 μg mL-1 and 58.9 μg mL-1 respectively. The study concluded that DBA/CD at 1:1 molar ratio has the potential to decrease the intrinsic toxicity of plain DBA towards Leishmania host cells, which may be a therapeutic advantage in the application of these compounds.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Beta-cyclodextrin; Curcumin; Dibenzalacetone; Leishmania major; Leishmaniasis

Mesh:

Substances:

Year:  2020        PMID: 32858130     DOI: 10.1016/j.ijpharm.2020.119764

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.

Authors:  Rahul Kumar; Amit K Thakur; Nilanjana Banerjee; Ashutosh Kumar; Gajendra Kumar Gaurav; Raj Kumar Arya
Journal:  Drug Deliv Transl Res       Date:  2022-08-11       Impact factor: 5.671

2.  Enhanced oral bioavailability of koumine by complexation with hydroxypropyl-β-cyclodextrin: preparation, optimization, ex vivo and in vivo characterization.

Authors:  Qing Hu; Xiaoling Fu; Yanping Su; Yanfang Wang; Sihuan Gao; Xiaoqin Wang; Ying Xu; Changxi Yu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

3.  Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin.

Authors:  Yixing Lu; Liuye Yang; Wanying Zhang; Shiting Xie; Feifei Zhao; Xianfeng Peng; Zonghua Qin; Dongping Zeng; Zhenling Zeng
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.